CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...